加载中
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
收盘时
US$1.61
US$0.00 · 0.00%
盘后
US$1.61
US$0.00 · 0.00%
10月12日 16:39 ET
盘中时间采用ET。市场数据可能有所延迟。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日内区间
当前US$1.61
52周区间
当前US$1.61
盘中时间采用ET。市场数据可能有所延迟。
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
日内区间
当前US$1.61
52周区间
当前US$1.61
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 24.55亿 USD | 25.57亿 USD | 26.29亿 USD | 26.6亿 USD | 18.77亿 USD |
| 销货成本 | 8.34亿 USD | 8.69亿 USD | 9.06亿 USD | 9.54亿 USD | 6.26亿 USD |
| 毛利 | 16.22亿 USD | 16.88亿 USD | 17.22亿 USD | 17.06亿 USD | 12.51亿 USD |
| 销售、一般及管理费用 | 7.09亿 USD | 7.28亿 USD | 7.4亿 USD | 7.3亿 USD | 6.43亿 USD |
| 营业费用 | 15.5亿 USD | 19.63亿 USD | 24.57亿 USD | 56.31亿 USD | 13.38亿 USD |
| 利息支出 | 2.65亿 USD | 2.83亿 USD | 2.94亿 USD | 2.7亿 USD | 2.53亿 USD |
| 折旧和摊销 | 7.57亿 USD | 7.27亿 USD | 7.08亿 USD | 7.11亿 USD | 5.38亿 USD |
| 营业利润 | 7150万 USD | −2.76亿 USD | −7.35亿 USD | −39.26亿 USD | −8700万 USD |
| 净利润 | −2.01亿 USD | −6.37亿 USD | −9.11亿 USD | −39.6亿 USD | −2.71亿 USD |
公司数据更新于 2026年10月12日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
Avantis U.S. Small Cap Value ETFAVUV2561.31万0.08%308.51亿 USD0.25%US$119.94+0.25%
iShares Russell 2000 ETFIWM1488.46万0.02%787.4亿 USD0.19%US$277.9-0.37%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV1191.26万0.04%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Extended Market ETFVXF1021.04万0.01%954亿 USD0.05%US$233.52-0.63%
Dimensional - US Targeted Value ETFDFAT418.13万0.01%301.22亿 USD0.33%US$67.42+0.22%
Vanguard Russell 2000 ETFVTWO412.28万0.02%180亿 USD0.06%US$112.27-0.35%
EA Bridgeway Omni Small-Cap Value ETFBSVO384万0.16%23.91亿 USD0.45%US$28.50+0.46%
Schwab Fundamental U.S. Small Company Index ETFFNDA381.49万0.04%87.82亿 USD0.25%US$35.60-0.06%Avantis U.S. Small Cap Value ETFAVUViShares Russell 2000 ETFIWMU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATVanguard Russell 2000 ETFVTWOEA Bridgeway Omni Small-Cap Value ETFBSVOSchwab Fundamental U.S. Small Company Index ETFFNDAAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
